161 related articles for article (PubMed ID: 38805513)
1. Etiologies underlying subtypes of long-standing type 2 diabetes.
Bayoumi R; Farooqi M; Alawadi F; Hassanein M; Osama A; Mukhopadhyay D; Abdul F; Sulaiman F; Dsouza S; Mulla F; Ahmed F; AlSharhan M; Khamis A
PLoS One; 2024; 19(5):e0304036. PubMed ID: 38805513
[TBL] [Abstract][Full Text] [Related]
2. Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial).
Aoki Y; Hamrén B; Clegg LE; Stahre C; Bhatt DL; Raz I; Scirica BM; Oscarsson J; Carlsson B
PLoS One; 2021; 16(11):e0259372. PubMed ID: 34797832
[TBL] [Abstract][Full Text] [Related]
3. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Zaharia OP; Strassburger K; Strom A; Bönhof GJ; Karusheva Y; Antoniou S; Bódis K; Markgraf DF; Burkart V; Müssig K; Hwang JH; Asplund O; Groop L; Ahlqvist E; Seissler J; Nawroth P; Kopf S; Schmid SM; Stumvoll M; Pfeiffer AFH; Kabisch S; Tselmin S; Häring HU; Ziegler D; Kuss O; Szendroedi J; Roden M;
Lancet Diabetes Endocrinol; 2019 Sep; 7(9):684-694. PubMed ID: 31345776
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort.
Christensen DH; Nicolaisen SK; Ahlqvist E; Stidsen JV; Nielsen JS; Hojlund K; Olsen MH; García-Calzón S; Ling C; Rungby J; Brandslund I; Vestergaard P; Jessen N; Hansen T; Brøns C; Beck-Nielsen H; Sørensen HT; Thomsen RW; Vaag A
BMJ Open Diabetes Res Care; 2022 Apr; 10(2):. PubMed ID: 35428673
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal Risk Profiles Among Data-Driven Type 2 Diabetes Sub-Phenotypes: A
Gao H; Wang K; Zhao W; Zhuang J; Jiang Y; Zhang L; Liu Q; Ahmadizar F
Front Endocrinol (Lausanne); 2022; 13():828403. PubMed ID: 35464070
[TBL] [Abstract][Full Text] [Related]
6. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.
Slieker RC; Donnelly LA; Fitipaldi H; Bouland GA; Giordano GN; Åkerlund M; Gerl MJ; Ahlqvist E; Ali A; Dragan I; Festa A; Hansen MK; Mansour Aly D; Kim M; Kuznetsov D; Mehl F; Klose C; Simons K; Pavo I; Pullen TJ; Suvitaival T; Wretlind A; Rossing P; Lyssenko V; Legido-Quigley C; Groop L; Thorens B; Franks PW; Ibberson M; Rutter GA; Beulens JWJ; 't Hart LM; Pearson ER
Diabetologia; 2021 Sep; 64(9):1982-1989. PubMed ID: 34110439
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of type 2 diabetes and their association with outcomes in Korean adults - A cluster analysis of community-based prospective cohort.
Hwang YC; Ahn HY; Jun JE; Jeong IK; Ahn KJ; Chung HY
Metabolism; 2023 Apr; 141():155514. PubMed ID: 36746321
[TBL] [Abstract][Full Text] [Related]
8. Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study.
Wang F; Zheng R; Li L; Xu M; Lu J; Zhao Z; Li M; Wang T; Wang S; Bi Y; Xu Y; Ning G; Cai W
Front Endocrinol (Lausanne); 2021; 12():802114. PubMed ID: 35154005
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.
Li X; Yang S; Cao C; Yan X; Zheng L; Zheng L; Da J; Tang X; Ji L; Yang X; Zhou Z
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32808015
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of canagliflozin in diabetes subgroups stratified by data-driven clustering or a supervised machine learning method: a post hoc analysis of canagliflozin clinical trial data.
Zou X; Huang Q; Luo Y; Ren Q; Han X; Zhou X; Ji L
Diabetologia; 2022 Sep; 65(9):1424-1435. PubMed ID: 35802168
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population.
Zaghlool SB; Halama A; Stephan N; Gudmundsdottir V; Gudnason V; Jennings LL; Thangam M; Ahlqvist E; Malik RA; Albagha OME; Abou-Samra AB; Suhre K
Nat Commun; 2022 Nov; 13(1):7121. PubMed ID: 36402758
[TBL] [Abstract][Full Text] [Related]
12. Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort.
Wang W; Li X; Chen F; Wei R; Chen Z; Li J; Qiao J; Pan Q; Yang W; Guo L
Diabetes Metab Syndr; 2024 Jan; 18(1):102936. PubMed ID: 38171152
[TBL] [Abstract][Full Text] [Related]
13. The prevalence, risk factors, and screening measure for prediabetes and diabetes among Emirati overweight/obese children and adolescents.
Al Amiri E; Abdullatif M; Abdulle A; Al Bitar N; Afandi EZ; Parish M; Darwiche G
BMC Public Health; 2015 Dec; 15():1298. PubMed ID: 26704130
[TBL] [Abstract][Full Text] [Related]
14. Polygenic scores of diabetes-related traits in subgroups of type 2 diabetes in India: a cohort study.
Yajnik CS; Wagh R; Kunte P; Asplund O; Ahlqvist E; Bhat D; Shukla SR; Prasad RB
Lancet Reg Health Southeast Asia; 2023 Jul; 14():100182. PubMed ID: 37492423
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study.
Li X; Chen H
Lipids Health Dis; 2023 Nov; 22(1):200. PubMed ID: 37990237
[TBL] [Abstract][Full Text] [Related]
16. New and Unique Clusters of Type 2 Diabetes Identified in Indians.
Anjana RM; Pradeepa R; Unnikrishnan R; Tiwaskar M; Aravind SR; Saboo B; Joshi SR; Mohan V
J Assoc Physicians India; 2021 Feb; 69(2):58-61. PubMed ID: 33527813
[TBL] [Abstract][Full Text] [Related]
17. Diabetes duration and types of diabetes treatment in data-driven clusters of patients with diabetes.
Zhang J; Deng Y; Wan Y; Wang J; Xu J
Front Endocrinol (Lausanne); 2022; 13():994836. PubMed ID: 36457559
[TBL] [Abstract][Full Text] [Related]
18. Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study.
Preechasuk L; Khaedon N; Lapinee V; Tangjittipokin W; Srivanichakorn W; Sriwijitkamol A; Plengvidhya N; Likitmaskul S; Thongtang N
BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36581330
[TBL] [Abstract][Full Text] [Related]
19. Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trials.
Landgraf W; Bigot G; Frier BM; Bolli GB; Owens DR
Prim Care Diabetes; 2023 Aug; 17(4):379-385. PubMed ID: 37142540
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Inpatients With New-Onset Diabetes Mellitus in Eastern China: Based on Novel Clustering Analysis.
Song X; Lv Y; Huang N; Sun J; Yang T; Wang X; Zhang J; Zhou Z; Gao H; Li J; Zhang W; Yin H; Wei Q; Wang K; Li L
Front Endocrinol (Lausanne); 2022; 13():927661. PubMed ID: 35966053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
